FdaApplication
ANDA 202743
Identifiers
- fda_app_no: ANDA202743
Properties
| Property | Value |
|---|---|
| applicant_name | PADAGIS ISRAEL PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2014-05-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL |
1 product